Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALGEV - FR0000033888 - Common Stock

176 EUR
0 (0%)
Last: 11/26/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALGEV scores 4 out of 10 in our fundamental rating. ALGEV was compared to 108 industry peers in the Machinery industry. No worries on liquidiy or solvency for ALGEV as it has an excellent financial health rating, but there are worries on the profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGEV was profitable.
ALGEV had a positive operating cash flow in the past year.
In the past 5 years ALGEV has always been profitable.
ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALGEV's Return On Assets of 1.21% is on the low side compared to the rest of the industry. ALGEV is outperformed by 65.05% of its industry peers.
ALGEV has a worse Return On Equity (1.52%) than 67.96% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.76%, ALGEV is doing worse than 77.67% of the companies in the same industry.
ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.99%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

The Profit Margin of ALGEV (2.38%) is comparable to the rest of the industry.
ALGEV's Profit Margin has declined in the last couple of years.
ALGEV has a Operating Margin of 1.68%. This is in the lower half of the industry: ALGEV underperforms 75.73% of its industry peers.
In the last couple of years the Operating Margin of ALGEV has declined.
The Gross Margin of ALGEV (63.62%) is better than 87.38% of its industry peers.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGEV is destroying value.
ALGEV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALGEV has less shares outstanding
Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.69 indicates that ALGEV is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALGEV (3.69) is better than 79.61% of its industry peers.
ALGEV has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
ALGEV has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. ALGEV outperforms 88.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACC0.1
WACC7.92%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALGEV has a Current Ratio of 5.18. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALGEV (5.18) is better than 97.09% of its industry peers.
ALGEV has a Quick Ratio of 3.79. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
ALGEV's Quick ratio of 3.79 is amongst the best of the industry. ALGEV outperforms 97.09% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -96.89% in the last year.
The earnings per share for ALGEV have been decreasing by -17.19% on average. This is quite bad
The Revenue has been growing slightly by 2.81% in the past year.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 391.11, the valuation of ALGEV can be described as expensive.
Based on the Price/Earnings ratio, ALGEV is valued a bit more expensive than 69.90% of the companies in the same industry.
ALGEV is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.00 indicates a correct valuation of ALGEV.
60.19% of the companies in the same industry are more expensive than ALGEV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALGEV to the average of the S&P500 Index (36.12), we can say ALGEV is valued rather cheaply.
Industry RankSector Rank
PE 391.11
Fwd PE 13
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

ALGEV's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALGEV is more expensive than 62.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)110.24
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.79%, ALGEV has a reasonable but not impressive dividend return.
ALGEV's Dividend Yield is rather good when compared to the industry average which is at 2.47. ALGEV pays more dividend than 83.50% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, ALGEV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

117.62% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (11/26/2025, 7:00:00 PM)

176

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2025-10-30
Earnings (Next)N/A N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap132.00M
Revenue(TTM)148.53M
Net Income(TTM)3.29M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 391.11
Fwd PE 13
P/S 0.96
P/FCF N/A
P/OCF 30.56
P/B 0.61
P/tB 0.62
EV/EBITDA 13.3
EPS(TTM)0.45
EY0.26%
EPS(NY)13.53
Fwd EY7.69%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.27%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)110.24
PEG (5Y)N/A
Graham Number54.07
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.69
F-Score6
WACC7.92%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


How profitable is GEVELOT SA (ALGEV.PA) stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALGEV stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 7 / 10.


What is the expected EPS growth for GEVELOT SA (ALGEV.PA) stock?

The Earnings per Share (EPS) of GEVELOT SA (ALGEV.PA) is expected to grow by 3.55% in the next year.